Aurinia Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +205.6% | |
| – | -21.8% | +101.7% | -19.5% | +105.7% | +96.3% | +68.4% | -12.4% | -144.0% | – | -1.1% | -9.0% | -10.1% | -16.2% | -11.4% | -4.5% | +87.0% | +2.4% | -5.1% | -1.6% | +7.5% | -25.2% | +17.1% | +101.4% | -2.0% | +330.4% | +67.0% | -52.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -25.5% | -19.1% | +878.0% | +47.5% | -57.1% | +206.7% | +61.7% | +8.1% | +135.4% | +79.0% | +3.4% | +40.3% | -30.3% | -53.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -181.7% | – | +2,826.2% | -78.5% | +251.0% | -6.8% | +109.4% | -22.3% | – | – | – | |
| – | -273.8% | – | -295.9% | – | – | -152.9% | – | -110.7% | – | -189.5% | – | – | – | – | -65.3% | -334.4% | – | +20.4% | +15.6% | -453.1% | – | +122.8% | -578.6% | – | – | – | -261.2% | |
| – | -100.0% | – | +28.4% | +497.1% | -51.1% | -61.5% | -16.1% | +67.3% | -29.0% | -61.2% | -31.1% | -63.4% | +1,254.1% | -96.6% | +165.9% | -13.7% | -44.4% | -50.0% | +0.0% | +200.0% | +34.7% | +7,170.3% | -79.6% | -80.5% | +145.9% | -60.9% | -10.3% | |
| – | +108.6% | +5,240.0% | – | -1,009.9% | -36.8% | – | +648.1% | +159.5% | -51.5% | -103.6% | -51.0% | – | -177.5% | -97.3% | +14.5% | +28,155.6% | -99.8% | – | -180.1% | -99.2% | – | -2,132.5% | -34.3% | -41.6% | -88.9% | – | -183.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +212.3% | -100.0% | – | – | – | – | – | – | – | – | – | +773.5% | -98.3% | +139.8% | +8,605.4% | -97.7% | +5,975.1% | -20.3% | +13.8% | -100.0% | – | – | +143.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -577.4% | – | – | +0.0% | +0.0% | +0.0% | – | – | – | – | +19.6% | +9.6% | |
| – | +169.5% | +277.4% | +91.4% | -59.3% | +98.9% | -80.2% | +213.7% | -108.3% | – | -71.4% | -193.1% | – | -50.9% | -68.6% | +765.8% | +671.8% | -98.2% | +4,979.3% | +311.0% | -97.7% | +5,975.1% | -20.3% | +13.8% | -98.9% | -310.9% | +857.0% | +116.1% | |
| – | – | +5.8% | +793.5% | -144.0% | – | -523.3% | – | -352.1% | – | -131.3% | – | – | -119.0% | – | – | +1,168.6% | -181.2% | – | +271.7% | -137.8% | – | -117.9% | – | – | – | – | -109.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +207.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.